1. Интерстициальные болезни легких: практическое руководство. Под ред. Н.А.Мухина. М.: Литтерра, 2007.
2. Попова Е.Н. Лекарственно-индуцированные поражения легких. Атмосфера. Пульмонол. и аллергол. 2007; 2: 3–7.
3. Ben-Noun L. Drug-induced respiratory disorders: incidence, prevention and management. Drug Saf 2000; 23 (2): 143–64.
4. Camus P, Fanton A, Bonniaud P et al. Interstitial Lung Disease Induced by Drugs and Radiation. Respiration 2004; 71: 301–26.
5. Camus P, Foucher P, Bonniaud P et al. Drug-induced infiltrative lung disease. Eur Respir J 2001; 18: 93–100.
6. Cottin V, Cordier JF. Iatrogenic drug-induced bronchospasm, cough, and bronchiolitis. Etiologic and physiopathologic aspects. Rev Mal Respir 1996; 13 (4): 339–60.
7. Ernawati DK, Stafford L, Hughes JD. Amiodarone-induced pulmonary toxicity. Br J Clin Pharmacol 2008; 66 (1): 82–7.
8. http://www.pneumotox.com: Pneumotox® Website, 1997. Producers: Foucher P, Camus P.
9. Imokawa S, Colby TV, Leslie KO et al. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15: 373–81.
10. Muller NL, White DA, Jiang H et al. Diagnosis and management of drug-associated interstitial lung disease. British Journal of Cancer 2004; 91 (Suppl. 2): 24–30.
11. Rossi SE, Erasmus JJ, McAdams HP et al. Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations. Radiographics 2000; 20: 1245–59.